Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hematopoietic Cell Transplant: early-phase trial registry
5 of 7 indexed Hematopoietic Cell Transplant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Hematopoietic Cell Transplant: 7 US clinical trials tracked, 5 recruiting.
Hematopoietic Cell Transplant is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Center for International Blood and Marrow Transplant Research, running 1 of these trials.
Enrollment posture brief
Registry condition hematopoietic-cell-transplant
OPEN 5 | RECR 71% | LATE 0 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Hematopoietic Cell Transplant lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hematopoietic Cell Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hematopoietic Cell Transplant is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hematopoietic Cell Transplant trials is spread across many organizations.
Center for International Blood and Marrow Transplant Research accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Hematopoietic Cell Transplant trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Hematopoietic Cell Transplant splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Arkansas Children's Hospital Research Institute
NCT05550298
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
M.D. Anderson Cancer Center
NCT06639854
Cognitive Training Intervention and Attitudes Towards Genetics
University of Alabama at Birmingham
NCT03094026
Virtual Rehabilitation in HCT
Emory University
NCT05943964
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Northside Hospital
NCT06828796
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
St. Jude Children's Research Hospital
NCT05164016
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
Center for International Blood and Marrow Transplant Research
NCT03558386
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hematopoietic Cell Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hematopoietic Cell Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hematopoietic Cell Transplant page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Hematopoietic Cell Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Center for International Blood and Marrow Transplant Research sponsors the most Hematopoietic Cell Transplant trials on record, review their full trial history before evaluating a specific study. See Center for International Blood and Marrow Transplant Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic Cell Transplant condition card totals 7 registered trials; most-linked intervention ePRO survey; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.